MS SPASTICITY TREATMENT
ACT NOW. ASK NOW.
The Command Clinical Research Trial is currently evaluating the safety and effectiveness of an investigational oral medication that is similar to a currently approved medication, baclofen. The study medication is being evaluated to determine whether it is effective at treating spasticity with twice daily dosing.
The trial is currently enrolling participants from 35 sites across the United States. Approximately 200 men and women who suffer from spasticity due to MS are expected to participate in the trial.
Click here to learn more.
If you would prefer to speak to someone, please call 1-855-71-STUDY.
ACT NOW. ASK NOW.
The Command Clinical Research Trial is currently evaluating the safety and effectiveness of an investigational oral medication that is similar to a currently approved medication, baclofen. The study medication is being evaluated to determine whether it is effective at treating spasticity with twice daily dosing.
The trial is currently enrolling participants from 35 sites across the United States. Approximately 200 men and women who suffer from spasticity due to MS are expected to participate in the trial.
Click here to learn more.
If you would prefer to speak to someone, please call 1-855-71-STUDY.